Skip to content
Pharmaceutical Guidelines
Quality Is Policy
  • Home
  • Quality Assurance
    • List of SOP for Pharmaceutical Quality Assurance
    • SOP on Handling of Incidents and Deviations
    • SOP on Change control
    • SOP on Training of Employees
  • SOP Format
  • Quality Control
  • Production
  • Microbiology
  • Maintenance
  • EDQM
  • Analytical Method Validation
  • Process Validation
  • Drug Regulatory Affairs
  • ICH
  • cGMP
  • WHO
  • Blog
  • Contact Us
  • Gallery
  • Privacy Policy

Tag: USFDA

How to Investigate Out Of Specification(OOS) Test Results….??? ( USFDA Phase -II)

October 1, 2018 Admin 7 Comments

How to Investigate Out Of Specification(OOS) Test Results….??? ( USFDA Phase -II) Out Of Specification( OOS ) :-  The all…

Continue Reading →

Posted in: Uncategorized Filed under: Investigation, OOS, Out of Specification, Phase-I, Phase-II, USFDA

How to Investigate Out Of Specification(OOS) Test Results….???( USFDA Phase -I)

Admin 28 Comments

How to Investigate Out Of Specification(OOS) Test Results….??? ( USFDA Phase -I) Out Of Specification(OOS) :-  The all test results…

Continue Reading →

Posted in: Uncategorized Filed under: Microbiology, Out of Specification, Out of Trend, Phase-I, Quality Control, USFDA

What is Data Integrity In Pharmaceutical Industry…???

September 29, 2018 Admin 2 Comments

What is Data Integrity In Pharmaceutical Industry…??? MHRA says,”The way regulatory data is generated has continued to evolve in line…

Continue Reading →

Posted in: Uncategorized Filed under: Audit Trail, Data Integrity, EU Audit Requirements, MHRA, Quality Control, USFDA

Pages

  • Analytical Method Validation
  • Blog
  • cGMP
  • Contact Us
  • Drug Regulatory Affairs
  • EDQM
  • Gallery
  • Home
  • ICH
  • Maintenance
  • Microbiology
  • Privacy Policy
  • Process Validation
  • Production
  • Quality Assurance
  • Quality Control
  • SOP Format
  • SOP List For Pharmaceutical Quality Assurance
  • SOP on Change control
  • SOP on Handling of Incidents and Deviations
  • SOP on Training of Employees
  • WHO

Blog Stats

  • 60,795 hits
Follow Pharmaceutical Guidelines

Pharmaceutical Guideline

Pharmaceutical Guideline

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 12,556 other subscribers

Contact Us

  • Email
    admin@pharmaguideline.net

Tags

Antibiotic Potency Testing Audit Preparation Audit Trail CAPA Change Management System Climatic Zone Clinical Trial/Study Corrective Action and Preventive Action Data Integrity Drain Points Monitoring E6(R1) EU Audit Requirements EU Reference EU requirments GDP GOOD CLINICAL PRACTICE Good Documentation Practice ICH Guideline ICH Q10 Interview Questions Investigation Manufacturing Site MHRA Microbiology OOS Out of Specification Out of Trend Pharmaceutical Production Pharmaceutical Quality System Phase-I Phase-II production Qualifications Protocol Qualification  Steps Quality Assurance Quality Control Regulatory Affairs Interview SOP Specification Stability Testing Sterile Pharmaceutical products Sterility Testing Testing Procedure USFDA WHO
  • LinkedIn
  • Google+
  • Twitter
  • Facebook
  • Home
  • Quality Assurance
  • SOP Format
  • Quality Control
  • Production
  • Microbiology
  • Maintenance
  • EDQM
  • Analytical Method Validation
  • Process Validation
  • Drug Regulatory Affairs
  • ICH
  • cGMP
  • WHO
  • Blog
  • Contact Us
  • Gallery
  • Privacy Policy
Privacy Policy
Copyright © 2018 - 2019 Pharmaguideline